RECRUITINGOBSERVATIONAL
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis
About This Trial
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
Who May Be Eligible (Plain English)
Who May Qualify:
- aortic stenosis detected by echocardiography / invasively
Who Should NOT Join This Trial:
- acute coronary syndrome
- endocarditis
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* aortic stenosis detected by echocardiography / invasively
Exclusion Criteria:
* acute coronary syndrome
* endocarditis
Treatments Being Tested
PROCEDURE
Aortic Valve Intervention (surgical or transcatheter)
Surgical or interventional aortic valve implantation
Locations (1)
Medical University Innsbruck
Innsbruck, Tyrol, Austria